Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks

OBJECTIVE: To identify factors predicting response (2‐hour headache pain freedom or most bothersome symptom freedom) to lasmiditan based on individual patient characteristics, migraine disease characteristics, and migraine attack characteristics. Further, efficacy specifically in difficult‐to‐treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Vasudeva, Raghavendra, Krege, John H., Rathmann, Suchitrita S., Doty, Erin, Vargas, Bert B., Magis, Delphine, Komori, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496706/
https://www.ncbi.nlm.nih.gov/pubmed/32634275
http://dx.doi.org/10.1111/head.13897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496706/
https://www.ncbi.nlm.nih.gov/pubmed/32634275
http://dx.doi.org/10.1111/head.13897

Ejemplares similares